[Astrocytes in the pathogenesis of multiple sclerosis]

Area of Science:

• Neuroimmunology
• Central Nervous System Disorders
• Autoimmune Diseases

Background:

• Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS).
• MS pathogenesis involves autoimmune responses targeting the myelin sheath, with T and B cells playing key roles.
• Current treatments effectively manage relapsing-remitting MS but lack efficacy for progressive forms.

Purpose of the Study:

• To review the pathology of multiple sclerosis.
• To discuss recent advances in disease-modifying therapies for relapsing-remitting MS.
• To highlight the emerging role of glial cells, including astrocytes, in MS immunopathology.

Main Methods:

• Review of existing literature on MS pathology and treatments.
• Analysis of experimental autoimmune encephalomyelitis (EAE) mouse models.
• Examination of the involvement of glial cells in MS.

Main Results:

• Adaptive immunity is central to MS, leading to effective therapies for relapsing-remitting MS.
• Glial cells, in addition to immune cells, are increasingly recognized as critical in MS.
• Astrocytes show involvement in MS pathology, as evidenced by research in EAE models.

Conclusions:

• While relapsing-remitting MS has seen therapeutic advances, progressive MS treatment remains a challenge.
• Understanding the complex interactions between immune cells, glial cells, and neurons is crucial for future MS therapies.
• Further research into astrocyte involvement may reveal new therapeutic targets for MS.